BioProgress plc announces - Additional Listing
December 13, 2004 07:17 ET
|
BioProgress PLC
Cambridge, UK, Dec. 13, 2004 (PRIMEZONE) --
BioProgress plc (the "Company")
BioProgress plc, a provider of innovative delivery mechanisms for the pharmaceutical oral dosage...
Graham Dixon joins Galapagos as Chief Scientific Officer
November 30, 2004 02:06 ET
|
Crucell N.V.
MECHELEN, Belgium and LEIDEN, The Netherlands, Nov. 30, 2004 (PRIMEZONE) -- Galapagos announced today that Graham Dixon has been appointed Chief Scientific Officer (CSO). Dr. Dixon will be...
Discovery Laboratories added to NASDAQ Biotech Index
November 15, 2004 08:00 ET
|
Discovery Laboratories, Inc.
DOYLESTOWN, Pa., Nov. 15, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), today announced that it was selected for addition to the NASDAQ Biotechnology Index (NBI) effective as of the...
Astex achieves drug discovery collaboration success with Schering AG
October 25, 2004 02:34 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 25, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that it has completed a significant goal in its multi-target...
Duke University Study Abstract Shows Significantly Lower Incidence of Major Adverse Cardiac Events Following Percutaneous Coronary Intervention Using Visipaque Compared to Isovue
November 19, 2003 07:12 ET
|
Amersham plc
BUCKINGHAMSHIRE, U.K., Nov. 19, 2003 (PRIMEZONE) -- The findings of a Duke University study abstract that were reported at the American Heart Association meeting November 9-12 in Orlando, Florida,...
LifePoint to Present at Biotech In Europe Investor Forum
October 06, 2003 08:30 ET
|
LifePoint, Inc.
ONTARIO, Calif., Oct. 6, 2003 (PRIMEZONE) -- LifePoint, Inc. (AMEX:LFP), a leader in non-invasive drug diagnostic technologies and solutions, announced today that it will be presenting at the Third...
GeneMedix plc -- Placing of New Shares for Cash
June 13, 2003 04:08 ET
|
GeneMedix plc
SUFFOLK, U.K., June 13, 2003 (PRIMEZONE) -- GeneMedix plc ("GeneMedix" or "the Company") (LSE:GMX), the U.K. multi-sourced biopharmaceutical company with operations in Europe and Asia and with joint...
CeNeS Announces Licensing Deal with Acorda for its Multiple Sclerosis Drug Candidate
November 13, 2002 04:04 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Nov. 13, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced that it had signed an agreement to out-licence its recombinant glial growth factor...